Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
deals
life sciences
national blog main
national top stories
san francisco blog main
san francisco top stories
3
×
startups
3
×
boston top stories
cancer
crispr
detroit blog main
detroit top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
abbvie
accelerator
airbnb
akouos
allergan
alnylam pharmaceuticals
amag pharmaceuticals
amazon web services (aws)
amunix
anirvan ghosh
artificial intelligence (a.i.)
astrazeneca
athelas
atomwise
benchling
What
years
3
×
bio
medicines
sciences
acquisitions
admits
ago
announced
big
biotechs
ceo
classes
collabs
combinator
companies
covid
create
crispr
daniel
deal
diagnostic
diseases
dug
editing
fix
gene
gilead
gilead’s
heats
help
high
human
incubator
introduce
ipo
launches
life
month
o’day
plans
Language
unset
Current search:
startups
×
years
×
" san francisco top stories "
×
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Five Years After Y Combinator First Admits Biotechs, They’re Dug In
@xconomy.com
5 years ago
CRISPR Diagnostic Race Heats Up as Sherlock Bio Launches With $35M